Resources

Welcome to read and download our industry insights and expert content within the advanced biologics space.

Stockholm Uppsala life science cluster

The Stockholm Uppsala Life Science Cluster is a globally recognized hub for advanced therapy medicinal products (ATMPs) and biomanufacturing. This region, encompassing...

Read the article

Strengthening Sweden’s resilience through pharmaceutical manufacturing

In an increasingly unstable world, Sweden is taking decisive steps to secure access to critical pharmaceuticals during crises and war....

Read the article

Progressing bacterial-derived extracellular vesicles to clinical stage

Bacterially derived extracellular vesicles (EVs) such as Outer Membrane Vesicles (OMVs) have emerged as an attractive new modality for both...

Read the article

Manufacturing stem cells for regenerative therapies

Stem cells have revolutionized the field of regenerative medicine, offering promising solutions for various medical conditions, including difficult-to-heal skin wounds....

Read the article

Driving therapeutic innovation with OMVs and EVs

Outer membrane vesicles (OMVs) and extracellular vesicles (EVs) are unlocking new possibilities in vaccines and therapeutics. OMVs, with their natural...

Read the article

Robotic gloveless isolator technology enhances regional production of advanced therapeutics

To meet growing demands of advanced therapy manufacturing, production architectures must shift towards agile, efficient manufacturing systems. By integrating robotic...

Read the article

What are extracellular vesicles, outer membrane vesicles and exosomes?

This FAQ aims to provide a comprehensive understanding of EVs. Whether you’re new to the concept or looking to deepen...

Read the article

From lab to clinic: Large-scale recombinant protein production explained

Recombinant protein manufacturing has transformed biotechnology, enabling the production of therapeutic proteins, industrial enzymes, and bioengineered materials. The growing demand...

Read the article

Personalized medicine and the CDMO: Adapting to a new era of healthcare

Neoantigen cancer vaccines represent a groundbreaking advancement in personalized medicine, offering tailored cancer treatments designed for each patient’s unique tumor...

Read the article

The expanding biologics CDMO market: Innovative modalities and the role of NorthX Biologics

The pharmaceutical industry is experiencing a rapid transformation as advanced biologics – viral vectors, recombinant proteins, plasmid DNA, and cell...

Read the article

Protein science and the future of biotherapeutics

The study of proteins is transforming our understanding of human biology and disease, enabling breakthroughs in diagnostics, drug development, and...

Read the article